Sign In
Buy CI
$270.73
-1.99 (-0.730%)
At Close: Jun 03, 2026
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
Cigna Corporation (CI) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Tuesday, 14'th Feb 2023
Cigna (CI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Compounders And Dividends: February 2023 Watch List Update
03:35am, Saturday, 11'th Feb 2023
Three companies have been removed from my watchlist and added to the active portfolio. I added four new companies to my watchlist.
Jeff Auxier's Auxier Asset Management 4th-Quarter and Full-Year 2022 Report
05:06pm, Thursday, 09'th Feb 2023
Moderating inflation, declining longer-term interest rates and a depreciating US dollar contributed to a rebound in stocks for the fourth quarter. The S&P 500 gained 7.56% for the quarter but declined
Will CVS's $10.6 billion acquisition of Oak Street enhance its health-insurance and pharmacy businesses?
11:43pm, Wednesday, 08'th Feb 2023 MarketWatch
The acquisition will provide new revenue at a time when growth in the company's legacy pharmacy and retail businesses is expected to slow down.
Prudential Financial (PRU) Q4 Earnings Miss, Decrease Y/Y
02:43pm, Wednesday, 08'th Feb 2023 Zacks Investment Research
Prudential Financial's (PRU) fourth-quarter results reflect a poor performance across most of the segments, lower premiums and net investment income, offset by lower expenses.
Assurant (AIZ) Q4 Earnings & Revenues Beat, Premiums Rise Y/Y
01:37pm, Wednesday, 08'th Feb 2023 Zacks Investment Research
Assurant's (AIZ) Q4 results reflect higher average insured values, premium rates and lender-placed policies in force and growth in Connected Living, partly offset by higher expenses.
CVS' purchase of Oak Street Health would help the pharmacy's primary-care goals, analysts say
04:58pm, Tuesday, 07'th Feb 2023 MarketWatch
CVS Health is reportedly getting close to buying Oak Street Health for $10.5 billion
What 7 Analyst Ratings Have To Say About Cigna
01:00pm, Tuesday, 07'th Feb 2023 Benzinga
Analysts have provided the following ratings for Cigna (NYSE:CI) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
5
1
0
0
Last 30D
0
1
Ensign Group (ENSG) Shares Down 2% Since Q4 Earnings Release
04:17pm, Monday, 06'th Feb 2023 Zacks Investment Research
Ensign Group's (ENSG) fourth-quarter results indicate higher skilled services revenue and improved occupancies, partly offset by the increased cost of services.
5 Relatively Safe And Cheap Dividend Stocks To Invest In - February 2023
02:00pm, Saturday, 04'th Feb 2023 Seeking Alpha
This is part of our monthly series where we highlight 5 companies that are large-cap, relatively safe, dividend-paying, and offer discounts. Click here for more.
5 Relatively Safe And Cheap Dividend Stocks To Invest In - February 2023
09:00am, Saturday, 04'th Feb 2023
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms. It's alwa
Cigna (CI) Q4 2022 Earnings Call Transcript
08:00pm, Friday, 03'rd Feb 2023 The Motley Fool
CI earnings call for the period ending December 31, 2022.
Cigna (CI) Q4 Earnings Top on U.S. Commercial Unit, Dividend Up
06:03pm, Friday, 03'rd Feb 2023 Zacks Investment Research
Cigna's (CI) fourth-quarter results reflect the strong contribution from the Evernorth segment. Management sanctions a 10% increase in the quarterly dividend.
Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say
05:24pm, Friday, 03'rd Feb 2023 Zacks Investment Research
While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to
